Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously
provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in …
provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in …
[HTML][HTML] Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review
CC Lai, JH Wang, PR Hsueh - International Journal of Infectious Diseases, 2020 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing the coronavirus
disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently …
disease 2019 (COVID-19), has led to a global pandemic. However, the majority of currently …
[HTML][HTML] Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?
CC Lai, CY Wang, PR Hsueh - Journal of Microbiology, Immunology and …, 2020 - Elsevier
Co-infection has been reported in patients with severe acute respiratory syndrome (SARS)
and Middle East respiratory syndrome, but there is limited knowledge on co-infection among …
and Middle East respiratory syndrome, but there is limited knowledge on co-infection among …
[HTML][HTML] Increasing incidence of nontuberculous mycobacteria, Taiwan, 2000–2008
CC Lai, CK Tan, CH Chou, HL Hsu… - Emerging infectious …, 2010 - ncbi.nlm.nih.gov
To assess the species distribution and epidemiologic trends of nontuberculous mycobacteria,
we examined isolates from patients in Taiwan. During 2000–2008, the proportion …
we examined isolates from patients in Taiwan. During 2000–2008, the proportion …
[HTML][HTML] Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and …
CC Lai, YH Liu, CY Wang, YH Wang, SC Hsueh… - Journal of Microbiology …, 2020 - Elsevier
Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by …
[HTML][HTML] COVID-19 associated with pulmonary aspergillosis: A literature review
CC Lai, WL Yu - Journal of Microbiology, Immunology and Infection, 2021 - Elsevier
Bacterial or virus co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been reported in many studies, however, the knowledge on Aspergillus co-…
have been reported in many studies, however, the knowledge on Aspergillus co-…
Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from …
CC Lai, CY Wang, CC Chu, CK Tan… - Journal of …, 2011 - academic.oup.com
Objectives: This study investigated the correlation between antibiotic consumption and
antimicrobial resistance in Gram-negative bacteria causing healthcare-associated infections at a …
antimicrobial resistance in Gram-negative bacteria causing healthcare-associated infections at a …
Extra-respiratory manifestations of COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most patients with …
coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most patients with …
Tocilizumab for severe COVID-19: a systematic review and meta-analysis
SH Lan, CC Lai, HT Huang, SP Chang, LC Lu… - International journal of …, 2020 - Elsevier
This systemic review and meta-analysis aimed to assess the efficacy of tocilizumab for the
treatment of severe coronavirus disease 2019 (COVID-19). Candidate studies up to 24 May …
treatment of severe coronavirus disease 2019 (COVID-19). Candidate studies up to 24 May …
Increased antimicrobial resistance during the COVID-19 pandemic
In addition to SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection itself,
an increase in the incidence of antimicrobial resistance poses collateral damage to the …
an increase in the incidence of antimicrobial resistance poses collateral damage to the …
